Arch Therapeutics, Inc.
(Other OTC/NBB : ARTH)

( )
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield

Message Boards

...

News

...
Health Technology » Biotechnology

Company Profile

Arch Therapeutics, Inc. is a development stage biotechnology company, which engages in the development of novel approach to stop bleeding, control leaking, and manage wounds during surgery, trauma, and interventional care. Its products candidates include AC5 Devices. The company was founded by Rutledge Ellis-Behnke and Terrence W. Norchi on September 16, 2009 and is headquartered in Framingham, MA.